SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-161574
Filing Date
2024-06-14
Accepted
2024-06-14 16:01:35
Documents
15
Period of Report
2024-06-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d835198d8k.htm   iXBRL 8-K 40175
2 EX-3.1 d835198dex31.htm EX-3.1 5000
  Complete submission text file 0001193125-24-161574.txt   217305

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eftrw-20240613.xsd EX-101.SCH 4379
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftrw-20240613_def.xml EX-101.DEF 14568
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftrw-20240613_lab.xml EX-101.LAB 24357
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftrw-20240613_pre.xml EX-101.PRE 15667
18 EXTRACTED XBRL INSTANCE DOCUMENT d835198d8k_htm.xml XML 6226
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 241044603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)